These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31731404)

  • 1. Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Casas K; Didycz B; Djordjevic M; Hertecant JL; Leuzzi V; Mathisen P; Nardecchia F; Powell KK; Rutsch F; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can untreated PKU patients escape from intellectual disability? A systematic review.
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Blau N; Bulut FD; Casas K; Didycz B; Djordjevic M; Federico A; Feillet F; Gizewska M; Gramer G; Hertecant JL; Hollak CEM; Jørgensen JV; Karall D; Landau Y; Leuzzi V; Mathisen P; Moseley K; Mungan NÖ; Nardecchia F; Õunap K; Powell KK; Ramachandran R; Rutsch F; Setoodeh A; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Orphanet J Rare Dis; 2018 Aug; 13(1):149. PubMed ID: 30157945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R; Moats R; Guttler F; Guldberg P; Nelson M
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual development and academic achievement of children treated early for phenylketonuria.
    Berry HK; O'Grady DJ; Perlmutter LJ; Bofinger MK
    Dev Med Child Neurol; 1979 Jun; 21(3):311-20. PubMed ID: 467815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrations.
    van Vliet D; Anjema K; Jahja R; de Groot MJ; Liemburg GB; Heiner-Fokkema MR; van der Zee EA; Derks TG; Kema IP; van Spronsen FJ
    Mol Genet Metab; 2015 Jan; 114(1):29-33. PubMed ID: 25466353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
    Didycz B; Bik-Multanowski M
    Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
    Bouchlariotou S; Tsikouras P; Maroulis G
    J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P; Hejcmanová L; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes beyond phenylalanine: an international perspective.
    Feillet F; MacDonald A; Hartung Perron D; Burton B
    Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients.
    Trefz F; Frauendienst-Egger G; Dienel G; Cannet C; Schmidt-Mader B; Haas D; Blau N; Himmelreich N; Spraul M; Freisinger P; Dobrowolski S; Berg D; Pilotto A
    Mol Genet Metab; 2024 May; 142(1):108464. PubMed ID: 38537426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cognitive and psychosocial outcomes in adults with phenylketonuria.
    Aitkenhead L; Krishna G; Ellerton C; Moinuddin M; Matcham J; Shiel L; Hossain S; Kiffin M; Foley J; Skeath R; Cleary M; Lachmann R; Murphy E
    J Inherit Metab Dis; 2021 Nov; 44(6):1353-1368. PubMed ID: 34145605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
    PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intelligence in phenylketonuria: a review of research and management.
    Brumm VL; Grant ML
    Mol Genet Metab; 2010; 99 Suppl 1():S18-21. PubMed ID: 20123465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring.
    Levy HL; Lobbregt D; Barnes PD; Poussaint TY
    J Pediatr; 1996 Jun; 128(6):770-5. PubMed ID: 8648535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of untreated phenylketonuria over 20 years.
    Pitt DB; Danks DM
    J Paediatr Child Health; 1991 Jun; 27(3):189-90. PubMed ID: 1909536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.